Navigation Links
$3 million grant to aid minorities with uncontrolled diabetes

Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy and College of Medicine have received a $3 million federal grant to improve diabetes management in minority patients.

The grant will fund a five-year study to evaluate a new intervention designed to improve lifestyle behaviors and medication compliance and to intensify therapy in minority patients with uncontrolled type 2 diabetes.

African-Americans and Latinos with diabetes often do not reach desired blood sugar, blood pressure or cholesterol levels, placing them at high risk for complications or death.

"We know there's a breakdown in the current health care system," said Lisa Sharp, assistant professor of medicine and co-principal investigator of the study. "Even when patients have access to quality health care, there are many other economic, social and cultural factors that contribute to them not meeting their therapeutic goals."

The researchers will enroll 300 African-American and Latino adults with uncontrolled diabetes from the University of Illinois Medical Center. Patients will be randomly assigned to one of two groups.

In the first group, a clinic-based pharmacist will educate patients about diabetes, reconcile their medications, and address any compliance barriers.

In the second group, a community-based lay health worker (or health promoter) will team with the clinic-based pharmacist to assist with cultural and language barriers, reinforce educational messages, provide support, help solve problems related to compliance, and assist in continuity of care.

"The pharmacist, working with a lay health worker, may help create a bridge, because there's this huge chasm between the patient and the health care provider," said Dr. Ben Gerber, associate professor of medicine. "A lot of times, people will leave their doctor's office, and they have a lot of questions and don't understand things."

For example, a physician may prescribe a new insulin pen, but the patient may not know how to use it properly. The pharmacist may demonstrate it, but some patients may need additional practice that can be reinforced by a health promoter. Language barriers may also hinder understanding.

After one year, the participants who didn't receive health promoters will begin to receive health promoter support, while health promoter support for the other group will be phased out to assess maintenance and clinical outcomes.

"There needs to be some adaptability to serve the patient's needs," said Gerber, co-principal investigator of the study.

Patients often bounce from the emergency room to the clinic to home and back again. Often there is a "hands-off" approach to figuring out what may be causing missed appointments or medication lapses, Gerber said.

Instead, we should "try to figure out what the problems might be because if we address them it might actually help their ability to come to the clinic, to take their medicine, and maybe prevent them from being hospitalized, especially for diabetes-related problems," Gerber said.


Contact: Sherri McGinnis Gonzalez
University of Illinois at Chicago

Related biology news :

1. CWRU receives $2.1 million NIH grant to expand cystic fibrosis research models
2. BUSM awarded $9 million to investigate treatment for sickle cell disease using iPS cells
3. 96-million-year-old fossil suggests prehistoric crocodile Terminonaris was Texas native
4. SPO Secures Equity Line Facility of US$5 Million
5. NSF sponsors $18.5 million effort to create mind-machine interface
6. Johns Hopkins researchers awarded $32 million
7. Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS
8. UTMB-led researchers awarded $7.8 million for Gulf spill study
9. NIH awards $17 million Program of Excellence Award in glycosciences to Brigham and Womens Hospital
10. Parkinsons Disease Foundation announces $1 million for novel studies into Parkinsons
11. Scripps awarded $7.9 million NIH grant for research to find root cause of heart attack
Post Your Comments:
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... ... November 24, 2015 , ... The United States Golf Association ... 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green Section Award ... work with turfgrass. , Clarke, of Iselin, N.J., is an extension specialist ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is ... it is bound to proteins, copper is also toxic to cells. With a ... Polytechnic Institute (WPI) will conduct a systematic study of copper in the bacteria ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology: